Tina M. Tagmose

NNC 55-0396 [(1 S,2 S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: A New Selective Inhibitor of T-Type Calcium Channels

Lüping Huang, Brian M. Keyser, Tina M. Tagmose et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 170 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans

Thomas Kjeldsen, František Hubálek, Claudia U. Hjørringgaard et al. · Journal of Medicinal Chemistry · 2021 · 124 citations

Medicine, Pharmacokinetics, Pharmacology +17

6-Chloro-3-alkylamino-4<i>H</i>-thieno[3,2<i>-e</i>]-1,2,4-thiadiazine 1,1-Dioxide Derivatives Potently and Selectively Activate ATP Sensitive Potassium Channels of Pancreatic β-Cells

Flemming Nielsen, Thora Bödvarsdóttir, Anne Worsaae et al. · Journal of Medicinal Chemistry · 2002 · 51 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320

Thomas Kjeldsen, František Hubálek, Tina M. Tagmose et al. · Journal of Medicinal Chemistry · 2020 · 39 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels

Søren Christian Schou, Holger C. Hansen, Tina M. Tagmose et al. · Bioorganic & Medicinal Chemistry · 2004 · 30 citations

Medicine, Medicinal Chemistry, Pharmacology +16